title: Interrogating the relationship between rat in vivo tissue distribution and drug property data for >200 structurally unrelated molecules.
abstract: The ability to explain distribution patterns from drug physicochemical properties and binding characteristics has been explored for more than 200 compounds by interrogating data from quantitative whole body autoradiography studies (QWBA). These in vivo outcomes have been compared to in silico and in vitro drug property data to determine the most influential properties governing drug distribution. Consistent with current knowledge, in vivo distribution was most influenced by ionization state and lipophilicity which in turn affected phospholipid and plasma protein binding. Basic and neutral molecules were generally better distributed than acidic counterparts demonstrating weaker plasma protein and stronger phospholipid binding. The influence of phospholipid binding was particularly evident in tissues with high phospholipid content like spleen and lung. Conversely, poorer distribution of acidic drugs was associated with stronger plasma protein and weaker phospholipid binding. The distribution of a proportion of acidic drugs was enhanced, however, in tissues known to express anionic uptake transporters such as the liver and kidney. Greatest distribution was observed into melanin containing tissues of the eye, most likely due to melanin binding. Basic molecules were consistently better distributed into parts of the eye and skin containing melanin than those without. The data, therefore, suggest that drug binding to macromolecules strongly influences the distribution of total drug for a large proportion of molecules in most tissues. Reducing lipophilicity, a strategy often used in discovery to optimize pharmacokinetic properties such as absorption and clearance, also decreased the influence of nonspecific binding on drug distribution.
authors.affiliation: Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development Ware, Hertfordshire, United Kingdom.
authors.forename: Andrew W
authors.initials: AW
authors.lastname: Harrell
authors.affiliation: Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development 709 Swedeland Road, King of Prussia, Pennsylvania, 19406.
authors.forename: Caroline
authors.initials: C
authors.lastname: Sychterz
authors.affiliation: Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development 709 Swedeland Road, King of Prussia, Pennsylvania, 19406.
authors.forename: May Y
authors.initials: MY
authors.lastname: Ho
authors.affiliation: Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development 709 Swedeland Road, King of Prussia, Pennsylvania, 19406.
authors.forename: Andrew
authors.initials: A
authors.lastname: Weber
authors.affiliation: Medicines Discovery Research, GlaxoSmithKline Research and Development Ltd Stevenage, Hertfordshire, United Kingdom.
authors.forename: Klara
authors.initials: K
authors.lastname: Valko
authors.affiliation: Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development 709 Swedeland Road, King of Prussia, Pennsylvania, 19406.
authors.forename: Kitaw
authors.initials: K
authors.lastname: Negash
keywords: Ionization; QWBA; lipophilicity; tissue distribution; transporters